4.6 Article

PD-1-induced proliferating T cells exhibit a distinct transcriptional signature

Journal

IMMUNOLOGY
Volume 164, Issue 3, Pages 555-568

Publisher

WILEY
DOI: 10.1111/imm.13388

Keywords

PD-1; proliferation; RNA sequencing; T cells

Categories

Funding

  1. NIH [AI125640, CA231277, AI150597]
  2. Cancer Research Institute

Ask authors/readers for more resources

The ligation of PD-1 inhibitory receptor on T cells results in the inhibition of cellular functions, but also activates a collection of functions. There are distinct transcriptomic and functional T cell populations responsive to PD-1 ligation, providing insights into the clinical differences observed following therapeutic PD-1 blockade.
Ligation of the inhibitory receptor PD-1 on T cells results in the inhibition of numerous cellular functions. Despite the overtly inhibitory outcome of PD-1 signalling, there are additionally a collection of functions that are activated. We have observed that CD4(+) T cells stimulated through the T-cell receptor and PD-1 primarily do not proliferate; however, there is a population of cells that proliferates more than T-cell receptor stimulation alone. These highly proliferating cells could potentially be associated with PD-1-blockade unresponsiveness in patients. In this study, we have performed RNA sequencing and found that following PD-1 ligation proliferating and non-proliferating T cells have distinct transcriptional signatures. Remarkably, the proliferating cells showed an enrichment of genes associated with an activated state despite PD-1 signalling. Additionally, circulating follicular helper T cells were significantly more prevalent in the non-proliferating population, demonstrated by enrichment of the associated genes CXCR5, CCR7, TCF7, BCL6 and PRDM1 and validated at the protein level. Translationally, we also show that there are more follicular helper T cells in patients that respond favourably to PD-1 blockade. Overall, the presence of transcriptionally and functionally distinct T cell populations responsive to PD-1 ligation may provide insights into the clinical differences observed following therapeutic PD-1 blockade.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

Affinity purification mass spectrometry analysis of PD-1 uncovers SAP as a new checkpoint inhibitor

Michael Peled, Anna S. Tocheva, Sabina Sandigursky, Shruti Nayak, Elliot A. Philips, Kim E. Nichols, Marianne Strazza, Inbar Azoulay-Alfaguter, Manor Askenazi, Benjamin G. Neel, Adam J. Pelzek, Beatrix Ueberheide, Adam Mor

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Biochemistry & Molecular Biology

D224V and S128Y mutation in FSHRED influence thumb movement differentially: An intricate insight gained by short-term molecular dynamics simulation

Fatemeh Rahimi Gharemirshamlu, Maliha Afsar, Taseem A. Mokhdomi, Asif Amin, Shoiab Bukhari, Anbarasu Krishnan, Chundi Vinay Kumar, Kourosh Bamdad, Trupti N. Patel, Raies A. Qadri, Naveed Anjum Chikan, Nadeem Shabir

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Article Multidisciplinary Sciences

SLAMF6 clustering is required to augment T cell activation

Matthew A. Dragovich, Kieran Adam, Marianne Strazza, Anna S. Tocheva, Michael Peled, Adam Mor

PLOS ONE (2019)

Article Immunology

PLCε1 suppresses tumor growth by regulating murine T cell mobilization

M. Strazza, K. Adam, A. Smrcka, S. Lerrer, A. Mor

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)

Review Cell Biology

The Complexity of Targeting Chemokines to Promote a Tumor Immune Response

Marianne Strazza, Adam Mor

INFLAMMATION (2020)

Article Biochemistry & Molecular Biology

Quantitative phosphoproteomic analysis reveals involvement of PD-1 in multiple T cell functions

Anna S. Tocheva, Michael Peled, Marianne Strazza, Kieran R. Adam, Shalom Lerrer, Shruti Nayak, Inbar Azoulay-Alfaguter, Connor J. R. Foster, Elliot A. Philips, Benjamin G. Neel, Beatrix Ueberheide, Adam Mor

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Lung cancer cell-derived EDA-containing fibronectin induces an inflammatory response from monocytes and promotes metastatic tumor microenvironment

Asif Amin, Taseem A. Mokhdomi, Shoiab Bukhari, Zubair Wani, Naveed A. Chikan, Basit A. Shah, Aabid M. Koul, Umer Majeed, Faizah Farooq, Ayub Qadri, Raies A. Qadri

Summary: Tumor-associated macrophages (TAMs) play a vital role in promoting tumor growth and metastasis by interacting with tumor cells. A prominent immunogenic protein, EDA(FN), secreted by A549 cells, drives the proinflammatory response and metastatic capacity through its cross-talk with monocytes.

JOURNAL OF CELLULAR BIOCHEMISTRY (2021)

Article Cell Biology

SHP2 Targets ITK Downstream of PD-1 to Inhibit T Cell Function

Marianne Strazza, Kieran Adam, Shalom Lerrer, Johanna Straube, Sabina Sandigursky, Beatrix Ueberheide, Adam Mor

Summary: PD-1 is a critical therapeutic target in cancer immunotherapy, with SHP2 playing a key role in its downstream signaling. Research has found that SHP2 specifically dephosphorylates ITK, which is associated with PD-1 inhibitory cellular functions. ITK may be a unique target in this pathway, and combining ITK inhibitors with PD-1 blockade may improve cancer treatment outcomes.

INFLAMMATION (2021)

Article Multidisciplinary Sciences

PD-1-stimulated T cell subsets are transcriptionally and functionally distinct

Shalom Lerrer, Anna S. Tocheva, Shoiab Bukhari, Kieran Adam, Adam Mor

Summary: Although PD-1 signaling has an inhibitory effect, it can also activate additional functions in T cells; T cells that proliferate more following PD-1 ligation are associated with effector and central memory phenotypes; the presence of transcriptionally and functionally distinct T cell populations responsive to PD-1 ligation provides new insights into the biology of PD-1 and suggests improving clinical outcomes of PD-1 blockade with T cell subset-specific approaches.

ISCIENCE (2021)

Article Biology

Transmembrane adaptor protein PAG is a mediator of PD-1 inhibitory signaling in human T cells

Marianne Strazza, Inbar Azoulay-Alfaguter, Michael Peled, Kieran Adam, Adam Mor

Summary: Strazza et al. demonstrate that PAG is phosphorylated following PD-1 ligation, and its deletion sensitizes tumors to PD-1 blockade. This study suggests that PAG is a critical mediator of PD-1 signaling and a promising target to enhance T cell activation in tumors.

COMMUNICATIONS BIOLOGY (2021)

Review Cell Biology

Bridging the Gap: Connecting the Mechanisms of Immune-Related Adverse Events and Autoimmunity Through PD-1

Adam Mor, Marianne Strazza

Summary: The emergence of immune checkpoint inhibitors has transformed the treatment of tumors, but challenges still remain such as non-responsive patients and immune-related adverse events. This review aims to bridge the gap between our understanding of PD-1 signaling, ICI-induced adverse events, and autoimmune diseases, and propose new therapeutic strategies.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Biology

SLAMF6 compartmentalization enhances T cell functions

Yevgeniya Gartshteyn, Anca. D. Askanase, Ruijiang Song, Shoiab Bukhari, Matthew Dragovich, Kieran Adam, Adam Mor

Summary: SLAMF6 clustering with the CD3 complex enhances T cell activity and shares downstream signaling pathways. Bispecific antibodies can modulate T cell responses.

LIFE SCIENCE ALLIANCE (2022)

Review Immunology

Eavesdropping on the conversation between immune cells and the skin epithelium

Shoiab Bukhari, Aaron F. Mertz, Shruti Naik

INTERNATIONAL IMMUNOLOGY (2019)

No Data Available